Figure 2.
Comparison the log2−delta CT of exo-miRNAs between HFrEF and CG. (A) exo-miR-92b-5p (Mann-Whitney U test; HFrEF vs. CG, P<0.001); (B) exo-miR-192-5p (Mann-Whitney U test; HFrEF vs. CG, P=0.050); (C) exo-miR-320a (Mann-Whitney U test; HFrEF vs. CG, P=0.087). HFrEF, heart failure with reduced ejection fraction; CG, control group.